Medicare Enrolled
Dr. Jeffrey Weisman, DO
Cardiovascular Disease · Trevose, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Weisman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weisman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Weisman
Dr. Jeffrey Weisman is a cardiovascular disease specialist in Trevose, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Weisman performed 2,018 Medicare services across 1,552 unique beneficiaries.
Between the years covered by Open Payments, Dr. Weisman received a total of $2,263 from 17 pharmaceutical and/or device companies across 90 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Weisman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 40% volume in PA
$2,263 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,018
Medicare services
Top 40% in PA for cardiovascular disease
1,552
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
392 | $94 | $200 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
245 | $156 | $525 |
| Ultrasound of arm arteries or grafts An ultrasound exam of the arteries in one arm or any arterial grafts present. This imaging test uses sound waves to visualize blood flow and vessel structure. |
245 | $82 | $350 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
238 | $11 | $63 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
171 | $150 | $595 |
| Injection, dipyridamole, per 10 mg | 84 | $3 | $20 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
55 | $20 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $120 | $250 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $44 | $125 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
41 | $74 | $200 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
40 | $50 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $69 | $150 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
37 | $13 | $28 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
33 | $689 | $2,200 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
32 | $50 | $250 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
32 | $21 | $225 |
| Ultrasound of abdominal aorta An imaging test that uses sound waves to create pictures of the abdominal aorta, the large blood vessel that carries blood from the heart to the lower body. |
30 | $113 | $250 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
23 | $42 | $225 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
23 | $192 | $450 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
21 | $189 | $390 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
20 | $352 | $1,295 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
20 | $31 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $145 | $250 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
19 | $6 | $17 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
17 | $27 | $44 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
17 | $1 | $9 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
16 | $69 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $65 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.9% high complexity
43.6% medium
43.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,263
Total received (2018-2024)
Avg $323/year across 7 years
Top 49% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
90
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,251 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,109
2023
$149
2022
$167
2021
$260
2020
$227
2019
$202
2018
$150
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$978
E.R. Squibb & Sons, L.L.C.
$31
Inspire Medical Systems, Inc.
$25
Novartis Pharmaceuticals Corporation
$22
AstraZeneca Pharmaceuticals LP
$22
Boston Scientific Corporation
$17
PFIZER INC.
$15
Top 3 companies account for 93.2% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$978
PFIZER INC.
$268
Novartis Pharmaceuticals Corporation
$260
Boehringer Ingelheim Pharmaceuticals, Inc.
$139
E.R. Squibb & Sons, L.L.C.
$128
Janssen Pharmaceuticals, Inc
$103
Preventice Services, LLC
$77
Amarin Pharma Inc.
$71
Intuitive Surgical, Inc.
$54
Boston Scientific Corporation
$42
AstraZeneca Pharmaceuticals LP
$33
Amgen Inc.
$33
Inspire Medical Systems, Inc.
$25
Abbott Laboratories
$14
ARALEZ PHARMACEUTICALS US INC.
$14
Cardinal Health 200 LLC
$14
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 66.5% of all-time payments
Associated products mentioned in payments ›
BREZTRI AEROSPHERE · CAMZYOS · CardioMEMS HF System · Carnation Ambulatory Monitor · Da Vinci Surgical System · ELIQUIS · ENTRESTO · FARXIGA · GENERAL PAIN MANAGEMENT · General - Therapies · INSPIRE · INTELLIS ADAPTIVESTIM · JARDIANCE · LEQVIO · PRADAXA · Repatha · Vascepa · WATCHMAN Access System · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
720
Per 100K population
111.5
County median income
$111,951
Nearest hospital
ST MARY MEDICAL CENTER
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Weisman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Weisman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Weisman performed 392 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weisman receive payments from pharmaceutical companies?
Yes. Dr. Weisman received a total of $2,263 from 17 companies across 90 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weisman's costs compare to other cardiologists in Trevose?
Dr. Weisman's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weisman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Trevose
Browse cardiologists in Trevose ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology